Skip to main content
. 2012 Mar 30;13(5):407–414. doi: 10.1007/s10194-012-0440-y

Fig. 2.

Fig. 2

Pain freedom at various time points after oral rizatriptan 10 mg (diamonds) intake during an acute migraine attack. Squares indicate the therapeutic gain (rizatriptan response–placebo response). Asterisks indicate a statistically significant (P < 0.05) therapeutic gain